Expansion of human bone marrow-derived mesenchymal stromal cells with enhanced immunomodulatory properties

BACKGROUND: Mesenchymal stromal cells (MSCs) have broad potential as a cell therapy including for the treatment of drug-resistant inflammatory conditions with abnormal T cell proliferation such as graft-versus-host disease (GVHD). Clinical success, however, has been complicated by the heterogeneity...

Descripción completa

Detalles Bibliográficos
Autores principales: Neo, Shu Hui, Her, Zhisheng, Othman, Rashidah, Tee, Ching Ann, Ong, Li Ching, Wang, Yuehua, Tan, Irwin, Tan, Jaylen, Yang, Yanmeng, Yang, Zheng, Chen, Qingfeng, Boyer, Laurie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510228/
https://www.ncbi.nlm.nih.gov/pubmed/37726837
http://dx.doi.org/10.1186/s13287-023-03481-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510228/
https://www.ncbi.nlm.nih.gov/pubmed/37726837
http://dx.doi.org/10.1186/s13287-023-03481-7

Ejemplares similares